DXCM

DEXCOM INC

DXCM·252131107·US·Common Stock·Healthcare - Medical Devices-13D/G

DXCM (DEXCOM INC) is held by 315 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.6B), VANGUARD CAPITAL MANAGEMENT LLC ($1.7B), VANGUARD PORTFOLIO MANAGEMENT LLC ($1.3B). Net institutional sentiment: Mixed. In Q2 2026, 3 members of Congress and 184 funds bought DXCM.

315
Holders
(23 Elite)
$23.5B
Total Value
58% (320)
Consensus
184 buying - 136 selling
13F: Insider & Congress: Updated regularly
DXCM

Smart Money Verdict

View all
Loading verdict
Held by 315 funds
23 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Sep 30, 2026 · Activists Apr 29, 2026 · Congress May 10, 2026

InsiderSSStern SadieSell $221KSep 28, 2026
InsiderBJBrown Michael JonSell $143KSep 15, 2026
InsiderANAUGUSTINOS NICHOLASSell $550KSep 15, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
38.2M(-1.9%)$2.6B0.0%+26.10%
0
Increased
25.2M(+0.8%)$1.7B0.0%+36.93%
32
Increased
19.7M(+2.3%)$1.3B0.1%+36.79%
33
Increased
18.4M(+2.5%)$1.2B0.0%+16.72%
33
Increased
15.3M(+11.8%)$1B0.1%+8.82%
36
Decreased
14.8M(-5.1%)$996.9M0.9%+61.78%
0
Increased
12.4M(+0.7%)$834.2M0.0%+19.69%
32
Increased
11.3M(+15.6%)$758.5M0.1%+9.65%
44
Decreased
11.7M(-9.5%)$734.3M0.2%+31.26%
0
Decreased
8.5M(-8.6%)$574.3M0.1%+34.43%
0
Increased
6.9M(+170.1%)$462.9M0.2%+28.13%
60
Increased
6.1M(+39.4%)$408.5M0.1%+20.70%
41
Decreased
5.6M(-11.5%)$377.4M0.1%+6.34%
0
Increased
5.2M(+2.3%)$347.3M0.0%-12.82%
32
Increased
4.8M(+13.7%)$324.7M0.1%+23.84%
35
Increased
3.9M(+382.7%)$260.7M1.2%+28.04%
78
Increased
3.8M(+23.5%)$253.1M0.0%+7.61%
37
Increased
3.6M(+37.9%)$242.2M0.1%-10.03%
40
Increased
3.6M(+84.1%)$240.9M0.1%+22.05%
48
Decreased
3.5M(-18.1%)$233M0.3%+36.85%
0

Showing 1-20 of 323

1 / 17
DXCMDXCMDEXCOM INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used